doi:10.1016/B978-0-12-420117-0.00003-7 [PubMed] 32
[DOI] [PubMed] [Google Scholar] 123.Du J, Liu X, Sun J, Wu Q, Hu Y, Shi H, et al
In summary, this investigation provides early evidence that the combination of GHRP-6, GHRP-2, and sermorelin can increase IGF-1 and testosterone levels in hypogonadal men already on testosterone therapy, while maintaining other hormones largely unchanged
In their separate Phase 2 trials, retatrutide monotherapy showed larger weight loss (~24.2% at 48 weeks, 12 mg) than standalone cagrilintide (~10.8% at 26 weeks, 4.5 mg), and indirect network meta-analyses rank retatrutide highly
Elizabeth has been a practising nurse for over 22 years and trained as an aesthetic practitioner for 7 years at Harley Street